Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Interactions between gut microbiota and berberine, a necessary procedure to understand the mechanisms of berberine
Hao Cheng, Juan Liu, Yuzhu Tan, et al.
Journal of Pharmaceutical Analysis (2021) Vol. 12, Iss. 4, pp. 541-555
Open Access | Times Cited: 92

Showing 1-25 of 92 citing articles:

Functions of Gut Microbiota Metabolites, Current Status and Future Perspectives
Juan Liu, Yuzhu Tan, Hao Cheng, et al.
Aging and Disease (2022) Vol. 13, Iss. 4, pp. 1106-1106
Open Access | Times Cited: 226
Interactions between polysaccharides and gut microbiota: A metabolomic and microbial review
Dandan Zhang, Juan Liu, Hao Cheng, et al.
Food Research International (2022) Vol. 160, pp. 111653-111653
Closed Access | Times Cited: 86
Hyperoside: A review on its sources, biological activities, and molecular mechanisms
Qi Wang, Hao‐Cheng Wei, Shengjun Zhou, et al.
Phytotherapy Research (2022) Vol. 36, Iss. 7, pp. 2779-2802
Closed Access | Times Cited: 79
Ginsenoside Rg1 Alleviates Acute Ulcerative Colitis by Modulating Gut Microbiota and Microbial Tryptophan Metabolism
Hao Cheng, Juan Liu, Dandan Zhang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 73
Gut microbiota remodeling: A promising therapeutic strategy to confront hyperuricemia and gout
Zhilei Wang, Yuchen Li, Wenhao Liao, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 73
Advancing green extraction of bioactive compounds using deep eutectic solvent-based ultrasound-assisted matrix solid-phase dispersion: Application to UHPLC-PAD analysis of alkaloids and organic acids in Coptidis rhizoma
Min Han, Kunze Du, Xicheng He, et al.
Talanta (2024) Vol. 274, pp. 125983-125983
Closed Access | Times Cited: 15
Nuciferine, an active ingredient derived from lotus leaf, lights up the way for the potential treatment of obesity and obesity-related diseases
Yan Wan, Jia Xia, Jinfeng Xu, et al.
Pharmacological Research (2021) Vol. 175, pp. 106002-106002
Closed Access | Times Cited: 55
Carotenoids Diet: Digestion, Gut Microbiota Modulation, and Inflammatory Diseases
Helena R. Rocha, Marta Coelho, Ana Gomes, et al.
Nutrients (2023) Vol. 15, Iss. 10, pp. 2265-2265
Open Access | Times Cited: 35
Oxyberberine ameliorates TNBS-induced colitis in rats through suppressing inflammation and oxidative stress via Keap1/Nrf2/NF-κB signaling pathways
Cailan Li, Meigui Liu, Li Deng, et al.
Phytomedicine (2023) Vol. 116, pp. 154899-154899
Closed Access | Times Cited: 29
The gut microbiota‐astrocyte axis: Implications for type 2 diabetic cognitive dysfunction
Zi-han Li, Yayi Jiang, Caiyi Long, et al.
CNS Neuroscience & Therapeutics (2023) Vol. 29, Iss. S1, pp. 59-73
Open Access | Times Cited: 26
Berberine activates PPARδ and promotes gut microbiota-derived butyric acid to suppress hepatocellular carcinoma
Jia‐Wen Shou, Pang‐Chui Shaw
Phytomedicine (2023) Vol. 115, pp. 154842-154842
Closed Access | Times Cited: 21
Dysbiosis of the gut microbiota and its effect on α-synuclein and prion protein misfolding: consequences for neurodegeneration
Nasir Uddin Mahbub, Md Minarul Islam, Seong‐Tshool Hong, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 11
Berberine prevents NAFLD and HCC by modulating metabolic disorders
Xinyue Lin, Jilei Zhang, Yajun Chu, et al.
Pharmacology & Therapeutics (2024) Vol. 254, pp. 108593-108593
Closed Access | Times Cited: 10
Overview of Panax ginseng and its active ingredients protective mechanism on cardiovascular diseases
Ziwei Zhou, Meijing Li, Zekuan Zhang, et al.
Journal of Ethnopharmacology (2024) Vol. 334, pp. 118506-118506
Closed Access | Times Cited: 7
Gut Microbiota: The Potential Key Target of TCM’s Therapeutic Effect of Treating Different Diseases Using the Same Method—UC and T2DM as Examples
Boxun Zhang, Ke Liu, Haoyu Yang, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 30
Protective Effects of Ferulic Acid on Metabolic Syndrome: A Comprehensive Review
Lei Ye, Pan Hu, Liping Feng, et al.
Molecules (2022) Vol. 28, Iss. 1, pp. 281-281
Open Access | Times Cited: 30
Dietary compounds in modulation of gut microbiota-derived metabolites
Wuwen Feng, Juan Liu, Hao Cheng, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 29
Role of herbal medicine and gut microbiota in the prevention and treatment of obesity
Qiao Zhang, Yaya Bai, Wenxiao Wang, et al.
Journal of Ethnopharmacology (2023) Vol. 305, pp. 116127-116127
Closed Access | Times Cited: 19
A Descriptive Review of the Action Mechanisms of Berberine, Quercetin and Silymarin on Insulin Resistance/Hyperinsulinemia and Cardiovascular Prevention
Paolo Bellavite, Sergio Fazio, Flora Affuso
Molecules (2023) Vol. 28, Iss. 11, pp. 4491-4491
Open Access | Times Cited: 17
The role of autophagy in insulin resistance and glucolipid metabolism and potential use of autophagy modulating natural products in the treatment of type 2 diabetes mellitus
Xiaoxue Yang, Wenwen Ding, Ziyi Chen, et al.
Diabetes/Metabolism Research and Reviews (2024) Vol. 40, Iss. 1
Closed Access | Times Cited: 6
Oral delivery of berberine by liver-targeted zwitterionic nanoparticles to overcome multi-intestinal barriers and extend insulin treatment duration
Yuhong Ma, Caihua Li, Fuwei Han, et al.
Chemical Engineering Journal (2024) Vol. 485, pp. 150129-150129
Closed Access | Times Cited: 6
A combination of faecal and intratumour microbial community profiling reveals novel diagnostic and prognostic biomarkers for pancreatic tumours
Wei Wang, Cheng Qian, Ting Wang, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 6
Open Access | Times Cited: 6
Effects of plant natural products on metabolic-associated fatty liver disease and the underlying mechanisms: a narrative review with a focus on the modulation of the gut microbiota
Tianqi Cai, Xinhua Song, Xiaoxue Xu, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 5
Clinically Effective Molecules of Natural Origin for Obesity Prevention or Treatment
Gladys Maribel Hidalgo-Lozada, Angélica Villarruel‐López, Karla Nuño, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2671-2671
Open Access | Times Cited: 5
Oxyberberine alleviates lipopolysaccharide-induced intestinal barrier disruption and inflammation in human colonic Caco-2 cells in vitro
Cailan Li, Jiahao Wang, Hongmei Yang, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access
Page 1 - Next Page

Scroll to top